Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.
The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported a mix of equity award exercises and share disposals. On February 17, 2026, she exercised 2,017 Restricted Stock Rights, receiving an equal number of common shares at a stated price of $0.00 per share.
To cover tax obligations, 992 common shares were disposed of at $701.12 per share, and an additional 318 common shares were sold in the open market at $702.56 per share under a Rule 10b5-1 trading plan adopted on October 30, 2025. After these transactions, she directly held 4,619.39 common shares and 6,513 Restricted Stock Rights, alongside 115.9291 common shares held indirectly in the Northrop Grumman Savings Plan.
Northrop Grumman-related reporting person Michael A. Hardesty reported sales of company common stock. The filing lists proposed sales of $550,410.63 for 784 shares on 02/13/2026 and $501,609.04 for 716 shares on 02/17/2026. The record also references restricted stock vesting dated 02/17/2026 tied to compensation.
NOC filer submitted a Rule 144 notice to sell 512 shares of common stock. The filing lists the 512 shares as Restricted Stock Vesting from 02/17/2026 under compensation.
It also discloses prior sales by Roshan Roeder of 84 shares on 12/09/2025 and 318 shares on 02/17/2026.
NOC reported a Form 144 filing showing a sale of securities by an insider. The filing shows 779 shares of common stock sold on 02/17/2026 for an aggregate of $547,294.24, with the disposition tied to restricted stock vesting.
NOC submitted a Form 144 indicating an intent to sell restricted common stock under Rule 144. The filing lists multiple vested lots: 4, 53, 188, 1, and 1,944 shares with vesting dates between 02/14/2022 and 02/11/2026
Northrop Grumman officer Michael A. Hardesty, Corp VP, Controller & CAO, reported two open-market sales of company common stock. On February 13, 2026, he sold 783 shares at $702.43 per share and 0.58 shares at $703.21 per share. Following these transactions, he directly owned 3,093.23 shares of Northrop Grumman common stock.
Northrop Grumman’s affiliate NOC insider plans stock sale under Rule 144. A person named Roshan Roeder filed a notice to sell 320 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 223414.08, while 141,921,621 shares of common stock are outstanding.
The shares come from restricted stock that vested between 2021 and 2025 and were received as compensation from the issuer. During the past three months, the seller already disposed of 84 common shares for gross proceeds of 46649.40, indicating ongoing, modest liquidity transactions.
Northrop Grumman insider Michael A. Hardesty filed a notice to sell up to 716 shares of common stock. The shares have an aggregate market value of $501,609.04, with an approximate sale date of February 17, 2026 on the NYSE through Fidelity Brokerage Services LLC.
The securities were acquired on February 16, 2023 via restricted stock vesting as compensation from the issuer. The notice states that 141,921,621 shares of common stock were outstanding. It also reports that Hardesty sold 784 common shares on February 13, 2026 for gross proceeds of $550,410.63. By signing, he represents that he is not aware of any undisclosed material adverse information about the issuer.
A shareholder filed a notice to sell 779 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of 547294.24, on or about 02/17/2026 on the NYSE.
The filing notes that these shares were acquired from the issuer through restricted stock vesting as compensation on several dates between 02/17/2020 and 02/18/2025. The issuer had 141,921,621 shares outstanding at the time stated.
Northrop Grumman Corporation has expanded its board of directors and updated executive incentive plans. The board elected Admiral Christopher W. Grady, former vice chairman of the Joint Chiefs of Staff and a four-star U.S. Navy admiral with over 40 years of service, effective February 12, 2026, and increased the board size from 12 to 13 members. He will serve on the Audit and Risk Committee and the Policy Committee, receiving a $145,000 annual cash retainer, an additional $15,000 for Audit and Risk Committee service, and an annual equity grant of $182,500 in deferred stock units, all prorated for 2026. The board designated James S. Turley as Lead Independent Director effective May 20, 2026, succeeding Madeleine A. Kleiner, who is retiring at the 2026 annual meeting after reaching the board’s retirement age. The Compensation and Human Capital Committee and the board also approved 2026 goals under the company’s incentive plans and granted Restricted Performance Stock Rights for 2026–2028 and Restricted Stock Rights vesting in 2029, using metrics tied to cash flow, segment operating income, sales, strategic performance, cumulative free cash flow, return on invested capital and relative total shareholder return.